RBC Capital provided its key takeaways from NuVasive, Inc. (NASDAQ:NUVA) Investor Day, reiterating its outperform rating and $63 price target on the company’s shares.

There was no guidance update for Q3/2022 or color on 2023, but the company issued its long-range plan through 2027. Among key takeaways from the event, the analysts mentioned (1) 2027 targets look achievable with room for upside, including from M&A and/or divestitures, (2) the company is looking to deliver WW revenue CAGR of 6-7%, and (3) the company is looking to deliver $800 million-$1 billion in free cash flow by 2027.

Overall, the analysts believe the company is well positioned to continue to drive above-market growth and share gains in spine, with room for upside from M&A and divestitures.